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INTRODUCTION   
 
            Jaundice is a frequent manifestation of biliary tract disorders and the 
evaluation and  management of obstructive jaundice is a common problem 
faced by the general surgeon. 
      Obstructive jaundice is strictly defined as a condition  occurring due to a 
block in the  pathway between the site of  conjugation of bile in liver cells and 
the entry of bile into the  duodenum through the ampulla. The block may be 
intrahepatic or extra hepatic in the bile  duct.1.  
      Despite the technical advances, the operative modes of management of 
obstructive jaundice were associated with very high morbidity and mortality. 
Yet, during the last decade  significant advances have been made in our 
understanding with regard to the pathogenesis, diagnosis, staging and the 
efficacy of management of obstructive jaundice.2 .  
    Obstructive jaundice of varied  etiology is one of the cause s of admission to 
hospitals  across  North Karnataka. To diagnose the cause, site of obstruction 
and management of a case  of surgical jaundice is indeed  a challenging task for 
the surgeon. Hence, a comprehensive  study of the etiology, clinical 
presentation a nd management of obstructive jaundice is of  paramount 
importance in the appropriate management of these patients.   
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OBJECTIVES OF THE STUDY   
 
 To study the clinical history and presentation of obstructive jaundice.   
 
 To study the various causes and sites of obstruction of the biliary tree.   
 
 To study the different modalities of treatment of obstructive jaundice.   
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REVIEW OF LITERATURE   
 
Jaundice is a generic term, which describe s yellow pigmentation  of the 
skin, mucus  membrane or sclera.   
 Mention of jaundice is made in the works of Hippocrates (400 BC) who 
pointed out  that persistent jaundice may be due  to cancer or cirrhosis of liver. 
3.  Gallstones have been described in Chilean mummies since the second and 
third centuries AD. Galen in second  century AD in his humoral concept of 
disease attributed abnormalities of yellow bile, black bile, blood and  phlegma 
within the body to cause disease.3,4  
 
 Francis Glisson (1640), Abrahmson vater  (1720) and Ruggero Oddi 
(1887) refined  anatomy with description of sphincteric mechanism.3,4   
 
 Charcot (1877), discussed the symptoms associated with the passage of 
CBD stones  which were jaundice, pain abdomen and fever (Charcot 
triad).    
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 Telfer Reynold added hypotension and alte red mental status to Charcot’s 
triad   
 (Reynold’s Pentad) related to sepsis with cholangitis.5   
 
 Langenbunch performed first cholecystectomy in the year 1882.   
 
 Robert Abbe (1889) was the first to perform choledochotomy.   
 
 Lawson  Trait  performed  choledocholithotomy.   
 
 Ludwig Courvoisier (1843-1918) stated Courvoisier’s law.3    
 
Courvoisier’s law:  In obstruction of the common bile duct due to a stone, 
distension of the gall bladder seldom occurs, the organ usually is already 
shriveled. In  obstruction from other causes, distension is common. If there is no 
disease of gallbladder and  the obstruction is due  to a cancer of the ampulla, 
pancreas or bile duct, then the gallbladder may well be distended.   
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  l 
 William Stewart Halstead performed choledochoduodenal anastomosis 
for ampullary  carcinoma.   
 
 Emil Theoder Kocher’s introduced kocher’s incision and kocher’s 
maneuver.5   
 
 Charles McBurney – Transduodenal choledochotomy.   
 
 Hans Kehr – Invented T-tube.3   
 
 John B. Murphy – Cholecystoenterostomy avoiding choledochotomy.   
 
 The first mention of carcinoma of gallbladder was published in 1777 in 
Ratio  
 Mendendi of Maximillian Stall.    
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 Fredrich discussed carcinoma of gallbladde r and suggested the 
relationship between  gall bladder stone and cancer.3   
 
 Graham Cole (1925) – Oral cholecystography    
 
 Mirrizzi (1931) – Intraoperative cholangiography.   
 
 Okuda (1973) – CHIBA needle for percutaneous transhepatic 
cholangiography.   
 
 Wildegans of Germany (1953) introduced modern choledochoscope.   
 
 Shore and Shore (1965) – Flexible  choledochoscope.   
 
 Yamakawa (1975) – Percutaneous   transhepatic  cholangioscopy.   
 McCune and Oi (1970) – ERCP.   
 Kawai et al – Endoscopic papillotomy.   
 First laparoscopic CBD exploration by Philips Peterson. 
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ANATOMY   
 
Development   
 
  Liver develops from an endodermal bud that  arises from the 
ventral aspect of the gut, at the point of junction between foregut  
and midgut. The bud enlarges and soon shows a division into:    
 
 Cranial part – Pars hepatica    
 
 Caudal part – Pars cystica   
 
1.  Pars hepatica: divides into ri ght and left parts each of  which 
forms one lobe of the  liver.   
 
2.  Pars cystica: Gives origin to the gall bladder and to the cystic 
duct. The part of the hepatic bud proximal to the pars cystica 
forms the bile duct. Bile duct at first opens on the ventral aspect 
of the developing duodenum. But as a result of differential  
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growth of the duodenal wall and as a result of the rotation of  the 
duodenal loop, it  comes to open on the dorso-medial aspect of the 
duodenum along with the ventral pancreatic bud.6,7,8   
 
 
 
9 
 
Anomalies of the extrahepatic duct system   
A.  Abnormal length: Variation in the level at which the various ducts 
join each other.   
B.  Abnormal mode of termination   
 
 Cystic duct may join left side of the common hepatic duct   
 
 Cystic duct may end in the right hepatic duct   
 
 Cystic duct may pass anterior to the duodenum, before 
joining the common hepatic duct.   
 
 Bile duct may open into the pyloric, or even the cardiac 
end of the stomach.   
 
C.  Atresia: Parts of the duct system and sometimes the whole of 
it may be absent.   
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D.  Duplication: Parts of duct system may be duplicated.8   
 
   
 
   Liver is divided into two major portions,  the right lobe 
and left lobe, which are  respectively drained by right hepatic 
and left hepatic ducts. The right and left hepatic ducts  converge 
at the liver hilus to constitute the common hepatic duct. Cystic 
duct joins common hepatic duct to form common bile duct. The 
common bile duct courses downwards and backwards anterior to 
portal vein and lateral  to hepatic artery, in the porta hepatis. The   
common bile duct is divided into four part s: Supraduodenal, 
Retro duodenal, Para duodenal  and Intra duodenal. The retro 
duodenal portion  of the common bile duct approaches the   
second portion of duodenum obliquely accompanied  by the 
terminal part of duct of Wirsung  and opens in the duodenum at 
papilla of vater.6,9  
 
   
 
   
11 
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Blood supply     
 
  Gall bladder is supplied  by  cystic artery. The blood  suppl y 
to the biliary ducts is  derived from the hepatic, cystic and superi 
or pancreaticoduodenal  arteries. Veins drain  directly into liver 
or form  tributaries of the portal vein.  Gastroduodenal  branches 
to CBD  runs on the side of CBD at 3 ‘0’ clock and 9 ‘0’ clock 
position. Retro portal artery from celiac plexus runs posterior to 
portal vein to supply post-aspect of CBD.    
 
   
 
 Vascular anomalies  
(a).  Accessory cystic arteries – arising from right hepatic artery.  
(b). Accessory cystic artery – arising from left hepatic artery.  
(c). Hepatic artery- arising from superior mesenteric artery.   
(d). Accessory hepatic arteries arising from the coeliac trunk and   
Superior  mesenteric  arteries.   
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 (e). Anterior transposition of right hepatic artery and cystic 
artery   
  (f). Recurrent (caterpillar hump) right hepatic artery.   
 
 
   
 
Nerve supply   
 
              Consists of sympathetic and parasympathetic  fibres 
passing in the hepatic plexus and  being joined at the 
portahepatis by branches from the anterior vagal trunk.   
 
  PHYSIOLOGY   
                One of the major function liver is to secrete bile 
normally between 600 to 1200 ml/day.   
  Bile is secreted in two stages by the liver:   
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  Initially bile is secreted by liver hepatocytes, which is rich in 
bile acids, cholesterol and other organic constituents, which 
flow into bile canaliculi.   
 
  Next, the bile flows peripherally towards the interlobular septa, 
where the canaliculi  empty into larger ducts, the hepatic duct 
and common bile duct and then to duodenum  or  to gall bladder 
through cystic duct. 
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 Composition of bile   
 
 Water      97.5 gm/dl   
 
 Bile salts    1.1 gm/dl   
 
 Bilirubin   0.04 gm/dl   
 
 Cholesterol    0.1 gm/dl   
 
 Fatty acids   0.12 gm/dl   
 
 Lecithin    0.04 gm/dl   
 
 Na    145 mEq/L   
 
 K    5 mEq/L   
 
 Ca     5 mEq/L   
 
 Cl     100 mEq/L   
 
 HCO3     28 mEq/L   
 
16 
 
  Metabolism   
 
  Hepatic metabolism of bilirubin occurs in three phases:   
 
(1) Uptake        (2) Conjugation        (3) Excretion   
 
   
 
 
 
 
 
 
                             Metabolism and Excretion of Bilirubin   
 
I.   
  80-85%                                            
                                                                                               globin 
                                    haemoglobin                    
                                                                                                 heme 
 
                                                                                                                
                                                                                                     biliverdin 
 
                                                                                                     Bilirubin 
   
Reticuloendothelial system 
Destruction of senescent RBC 
Marrow destruction of maturing RBC 
Liver turnover of heme 
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Bilirubin + albumin 
                  PLASMA 
Bilirubin 
 
Bilirubin + ligadin 
                                 Glucuronyl transferase 
  Bilirubin monoglucouronide 
                    LIVER                                                 Glucuronyl transferase 
Bilirubin diglucouronide 
 
                                                                           Bile 
INTESTINE                                                                 Intestinal reabsorption 
Urobilinogens 
  Urinary excretion 
                KIDNEY                      Fetal excretion 
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Surgical Jaundice   
 
  A complete or partial obstruction of biliary flow can cause jaundice and this 
may be intra or extra hepatic.   
 
        Causes of surgical jaundice classified into:13   
 
A.  In the lumen of duct   
 Choledocholithiasis   
 
 Parasitic infestation due to: Hydatid disease, Ascariasis   
 
 Hemobilia   
 
B.  In the wall of duct   
 
         1.  Congenital   
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 Biliary atresia 
 Choledochal cyst   
 
          2.  Acquired   
 Papillary stenosis 
 Strictures  
  
a. Post-traumatic  
 
b. Post-surgical  
 
 .  Injuries at cholecystectomy 
 
  Exploration of CBD 
 
  Pancreatic operation 
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 Gastrectomy 
 
 Biliary enteric anastomosis 
 
 Operation on liver and portal vein 
 
 
 
c.  Post-inflammatory strictures 
               
 Gallstones 
 
 Chronic pancreatitis 
 
 Chronic duodenal ulcer 
 
 Parasitic inflammation 
 
 Recurrent pyogenic cholangitis 
21 
 
 
d. Primary sclerosing cholangitis 
 
e. Following radiotherapy 
 
f. Mirrizzi’s syndrome 
 
                    3. Malignant causes 
 
 Ca Gall bladder 
 
 Cholangiocarcinoma 
 
 Ca of ampulla of vater 
 
   
                 C. Outside the wall   
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1. Benign: Pseudocyst of pancreas 
                                      2.  Malignant: 
 Ca head of pancreas 
 Enlarged lymph nodes at portahepatitis 
 Periampullary Ca 
 Extra biliary malignancy 
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 PATHOPHYSIOLOGY OF BILIARY OBSTRUCTION   
 
  Cholestasis is defined as the failure of normal bile to reach the duodenum. It is  
classified as:    
 
1.  Extrahepatic  cholestasis   
 
2.  Intrahepatic cholestasis   
 
                Intrahepatic cholestasis: No demonstrable obstruction to  the major 
bile ducts. They  are caused due to drugs, hepatitis, hormones, Primary biliary 
cirrhosis and septicaemia.   
                     Extrahepatic cholestasis: encompasses conditions  where there is 
physical  obstruction to the bile ducts.  Cholestasis begins with distension  of 
the bile duct proximal to  the obstruction, including intrahepatic duct system.  
The bile stasis in the duct radicals within  the portal triads leads to pro liferation 
of the epithelial lining cells. Sometimes accompanied  by an increase in 
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surrounding fibrous tissue. Eventually the canaliculi become distended with  
bile. Distended canaliculi ruptures, which lead  to extravasation of bile 
producing so, called  bile lakes surrounded by injured or necrotic liver cells . 
Because stasis of bile predisposes to  ascending bacterial infections, 
extrahepatic cholestasis may be complicated by cholangitis.  Escherichia coli 
produce beta-glucuronidase, which may lead to deconjugation of bilirubin in  
bile. This may lead to the formation of primary common bile duct stones with a 
high bile  pigment as contents. 
.If obstruction continues, the reticulin laid down in the periportal area matures 
to hard  type, causing fibrosis around the bile duct, which may further aggravate 
the cholestasis.14,15  
 
Biochemical changes
10 , 16 
 
 
Bilirubin   
 
  Conjugated hyperbiliurubinaemia is the classic biochemical feature of 
obstructive jaundice. Conjugated bilirubin is water-soluble and penetration to 
body fluids is high, thus producing more jaundice than unconjugated pigment.   
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Alkaline phosphatase        
              The level rises in cholestasis and to a lesser extent when liver cell are 
damaged. The mechanisms of the increase are complex. Hepatic synthesis of the 
alkaline phosphatase by  the hepatocytes is increased and this depends on intact 
protein and RNA synthesis. 
 Gamma glutamyl transpeptidase (GGT)   
 
  Serum values are increased in cholestasis and hepatocellular diseases. Levels 
parallel serum alkaline phosphatase in cholestasis and ma y be used to confirm 
that a raised serum   phosphatase is of hepatobiliary origin. It is also elevated in 
alcohol intake, pancreatitis, chronic lung disease, renal failure and congestive 
heart failure.   
 
Protein synthesis   
 
                 The liver occupies a central role in protein synthesis and albumin is 
quantitatively the most important of plasma protein formed in th e liver. The 
relatively   long half-life of serum albumin (20 days) makes the serum albumin 
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level a better index of severity and prognosis in patients with chronic liver 
disease. Alteration in serum albumin levels may reflect not only disturbances in 
synthesis but also changes in the rate of catabolism, dilution by expanded 
plasma volume or enhanced loss from the gastrointestinal tract and kidneys. The 
most important aspect of protein synthesis relates to the liver in the maintenance 
of the normal blood coagulation process.   
 
  Clotting factors   
            Liver disease is a common cause of impaired coagulation. Normal serum 
activities of   the vitamin-K dependent coagulation factor proenzymes (factors 
II, VII, IX and X), as assessed by the one stage prothrombin time, depend on 
both intact hepatic synthesis and   adequate intestinal absorption of vitamin K.  
In cholestatic disease prolonged prothrombin time can be improved by 
parenteral administration of vitamin K. A characteristic pattern of abnormalities 
occurs in patients with severe liver dysfunction; it consists of low plasma 
fibrinogen level, a prolonged prothrombin time, and   a  normal or prolonged  
partial  thromboplastin time.   
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                                           ETIOPATHOGENESIS   
 
In the lumen of duct   
 
A. Choledocholithiasis   
                 Nearly all calculi found in the common b ile duct were originally 
formed in the gallbladder and migrate down the cystic duct in to the common 
bile duct. Calculi in common bile duct can be divided into:
 15, 17
  
 
1.  Primary common bile duct stones   
2.  Secondary common bile duct stones   
 
1.  Primary common bile duct stones
18, 19
  
                These stones are formed primarily in the CBD and do not originate 
from gallbladder.  These are caused due to bile duct stasis or du e to infection. 
Almost all calculi are pigment stones. They are solitary, ovoid, light brown in 
colour, soft and easily crushable.   
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            Disturbance in the flow of bile as well as  introduction of infected  
material into the  biliary tract, may be associated with previous operation that 
disturb the usual motility  dynamics of the sphincter, such as sphincterotomy, 
sphincteroplasty  and biliary enteric  anastomosis and also condition that 
obstruct the flow of bile into duodenum such as sphincter  fibrosis, chronic 
pancreatitis and periampullary  duodenal diverticula can lead to stasis of bile  
resulting in bile duct calculi and infection of biliary system.   
2.     Secondary common bile duct stones   
                 Are those that have migrated into the biliary system from the gall 
bladder.   
 
3.  Retained stones in common bile duct are those that present at some point in 
time following cholecystectomy with or without concomitant bile duct stone.   
 
B.  Hemobilia   
 
  Hemobilia is a rare cause of upper GI bleeding that most often results from 
blunt or penetrating hepatic injury, with fistula formation within the liver 
between a vascular structure and the biliary duct system. Jaundice occurs due  to 
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acute extrahepatic  biliary obstruction  owing to the blood clot formation in the 
common bile duct. Non-traumatic cause of hemobilia includes hepatic 
abscesses, choledocholithiasis or oriental cholangiohepatitis. 
   
C.  Parasitic infestation of bile duct   
1.  Ascariasis: It is the most common helminthic infestation of bile ducts, 
caused by  Ascariasis lumbricoides. In the presence of massive duodenal 
infestation the worms  can enter the biliary system.
20
  
2.  Clonorchiasis: It is endemic to Asia and is ca used by the liver fluke, 
clonorchis   sinensis, which is transmitted by ingestion of infected raw fish. The 
intrahepatic ducts are the natural habitat, where they cause obstruction,  
periductal inflammation and  fibrosis.
21
  
 
2. Echinococcus granulosus (Hydatid cyst) : It is the usual organism 
responsible for  hydatid disease. Large cysts in the liver may compress 
the intrahepatic biliary radicals and rupture into the bile duct and may re 
lease daughter cysts causing obstructive  jaundice and fibrotic change in 
the biliary tree.
22
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In the wall of duct   
1.  CONGENITAL 
 
a. Biliary atresia   
 
The occurrence of biliary atresia is embryological. Failure of vacuolization of 
the solid embryonic bile ducts filled by proliferating epithelial cells was 
supposed to produce this malformation. Probably only a small percentage of 
cases are congenital malformations or intrauterine catastrophies.23  
 
Types   
 
Type I:   Atresia of CBD, with a common hepatic duct remnant.   
 
Type II:  Atresia of common hepatic duct and bile duct with right and left duct   
remnants.   
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Type III:  Atresia of the extrahepatic ductal system.   
b. Choledochal cyst
24, 25 
 
                It is defined as an isolated or combined congenital dilatation of the 
extrahepatic and intrahepatic biliary tree. Mostly confined to extrahepatic 
biliary tree starting from bifurcation of right and left hepatic duct to the opening 
of pancreatic duct. Three theories have been stated for the formation of the cyst.   
 
 Anomalous pancreatic duct and biliary  duct junction – causes pancreatic  
reflux into common bile duct, leading to high-pressure in common bile 
duct.    
 Abnormal canalization of the bile duct during embryogenesis, with distal  
obstruction causing weakening of bile duct wall.   
 Abnormality of autonomic innervation of the extrahepatic tree.   
 
  Caroli’s Disease   
 
  It is a rare, congenital, non-familial condition, characterized by multiple 
sacular dilatation of intrahepatic ducts   separated by segments of normal or 
32 
 
stenotic ducts. Usually associated with congenital hepatic fibrosis, medullary 
sponge kidney, cholangiocarcinoma and stone formation
.24, 25
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   Todani’s Classification of Choledochal Cysts   
   
Type I – Dilatation of the extra-hepatic biliary tree, a-cystic, b-focal, c-fusiform   
   
Type II- Saccular diverticulum of extrahepatic bile duct   
   
Type III- Biliary tree dilatation within the duodenum: choledochocele   
   
Type IVa- Dilatation of intra and extra-hepatic biliary tree   
   
Type IVb- Multiple extrahepatic cysts 
   
Type V-Dilatation of intrahepatic ducts 
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2.  ACQUIRED   
        Papillary stenosis: It has been defined as an obstructive disease of the 
papilla, which is organic and benign. It is usually primary, of unknown 
pathogenesis or secondary to inflammation such as duodenal ulcer or 
pancreatitis or passed out common bile duct calculi.
26
   
   Benign biliary strictures   
                 Benign stenosis and strictures  of the bile ducts  occurs in number  of 
conditions and  may affect intrahepatic or extrahepatic biliary tree.   
 
  Causes    
 
A.  BILE DUCT INJURIES
27-30  
 
 
I.  Postoperative bile duct strictures   
             1.  Cholecystectomy and exploration of common bile duct   
              2.  Other operative procedures   
 Biliary enteric anastomosis   
 Operation of liver or portal vein   
 Pancreatic operation   
 Gastrectomy   
36 
 
 II. Stricture after blunt or penetrating injury 
   
 
  B.  POST-INFLAMMATORY STRICTURE WITH 
27,30 
             1. Cholelithiasis/Choledocholithiasis   
             2.  Chronic pancreatitis  
        3.  Chronic duodenal ulcer   
        4.  Abscess or inflammation in sub hepatic region 
        5.  Parasitic infection   
        6.  Recurrent pyogenic cholangitis   
 
  C.  Primary Sclerosing Cholangitis   
  D.  Radiation-induced Cholangitis   
  E.  Papillary Stenosis   
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Postoperative bile duct strictures   
            The great majority of injuries to the bile duct occur during 
cholecystectomy with or without exploration of the CBD. They also occur in 
other operation on either  the stomach, pancreas or liver or during surgeries for 
portal hypertension.
32
  
 
Number of factors relate to bile duct injury with cholecystectomy
29-32 
 
A.  Anatomical Variation   
       There are wide anatomical variations in extrahepatic biliary tree and 
adjacent hepatic artery and portal venous structure. Anomalies of the vessels are 
in the tune of 20% and hence very common. The most common for right hepatic 
artery to arise in whole or in part from the superior mesenteric trunk.  The 
important ductal anomalies are related to the manner of confluence of right and 
left hepatic ducts and of the cystic duct with the common hepatic  duct and bile 
duct anomalies mentioned earlier.   
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B.  Use of diathermy near Calot’s triangle.   
C.  Technical factors: Bile duct injuries occur following cholecystectomy 
performed by surgeons who are inadequately trained or inexperienced. Traction 
on the gallbladder while applying clips on the cystic duct ma y include a part of 
the CBD wall which leads to stricture formation. The hepatic duct or common 
bile duct is often assumed as the cystic duct and has been excised. 
D.  Attempts to control haemorrhage during cholecystectomy: There may be 
damage to the bile duct if clamps are applied blindly.   
E.  Bile duct ischaemia: Bile duct blood supply runs in three columns, one 
posterior and two lateral. It is suggested that damage to these vessels may result 
in ischaemia to the bile duct, with consequent necrosis and stricture.   
F.  Pathological factor: Acute cholecystitis may be accompanied by extensive 
edema in the region of porta hepatitis and Calot’s  triangle and there may be 
considerable  friability during dissection.
28
  
 
Primary sclerosing cholangitis   
          It has an unknown etiology. It is a progressive cholestatic disorder 
characterized by a fibrosing inflammatory process, which affects the 
intrahepatic and or extrahepatic ducts. It may occur alone or in association with 
inflammatory bowel disease. The strictures are  typically short and annular 
39 
 
alternating with normal or minimally dilated segments leading to  characteristic 
beaded appearance. 
 
   
 
       Classification of bile duct stricture 
32
(Bismuth Classification)   
 
Type I:   Low common hepatic duct stricture; hepatic duct stump > 2 cm.   
Type II:  Mid common hepatic duct stump < 2 cm   
Type III:  High stricture (Hilar)   
Type IV:  Destruction of hilar confluence   
Type V:  Involvement of sectoral right branch alone or with common duct   
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III. Malignant causes   
a.     Ca Gallbladder
35 ,36  
 
       This tumor represents only 2% of all cancers , but it is commonest site of 
cancer in  biliary tract.   
Etiology   
           75-98% of patients with gallbladder Ca has gallstones and also common 
in   the  presence of chronic cholecystitis. Others include Porcelain gallbladder 
(10-25% risk) Choledochal cyst, inflammatory bowel  disease, polyposis coli 
and Primary sclerosing  Cholangitis.   
Pathology   
        85% of gallbladder carcinoma is adenocarcinoma, other variants common 
are   mesenchymal tumors, carcinoid, lymphoma, squamous and 
adenosquamous carcinoma.   
 
 
 
 
41 
 
TNM staging for gallbladder Ca    
      Tumor Nodes Metastasis 
Stage 0       Tis N0 M0 
Stage 1        T1 N0 M0 
Stage 2         T2 N0 M0 
Stage 3         T3 N0 M0 
Stage 4         T1-3 N1 M0 
Stage 5         T4 Any N M0 
Stage 6     Any T Any N M1 
  
Tis:    Ca in situ   
T:    Tumor   limited to mucosa or muscularis   
T1:    Tumor   invades  perimuscular connective tissue or serosa    
T2:    Tumor invades liver (< 2 cm) or one adjacent organ.   
T3:    Tumor extends > 2 cm into liver or two or more adjacent organ. 
 
 
 
 
42 
 
 
   
   
              Nevin classification for staging for gallbladder carcinoma 
                                             Depth of tumor   
 
Stage I:   Mucosa   
Stage II:   Muscularis   
Stage III:   Serosa   
Stage IV:   Liver invasion   
Stage V:     Adjacent organ or distant metastasis   
 
b. Cholangiocarcinoma
38,39  
 
                  The incidence of bile duct tumors increases with age. Has even 
distribution between men and women. The most common is adenoc arcinoma 
(95%) and remaining are squamous, leiomyosarcoma, mucoepidermosis, 
carcinoid and cystadenocarcinoma.   
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          Causes of cholangiocarcinoma are Primary sclerosing cholangitis, 
choledochal cyst, liver fluke infestation, CBD stone, thorotrast and asbestos 
exposure.   
 
  
TNM staging for Extrahepatic Cholangiocarcinoma
40: 
  
T1:     Tumor limited to mucosa/muscle    
T2:    Tumor invades periductal tissue   
T3:     Tumor invades adjacent structure  
   
   
      Tumor Nodes Metastasis 
Stage IA       T1 N0 M0 
Stage IB        T2 N0 M0 
Stage IIA         T3 N0 M0 
Stage IIB         T1-3 M0 M0 
Stage III         T4 Any N M0 
Stage IV         Any T Any N M1 
     
 
44 
 
c.   Periampullary carcinoma
41
  
          Periampullary cancers include a group of malignant neoplasms arising at 
or near the ampulla of vater, within 2 cms of radius fr om ampulla. Most of 
them are adenocarcinoma arising from the head of pancreas (60%), ampulla of  
vater (20%), distal common bile  duct (10%) or second part of duodenum 
(10%).   
 
Risk factors 
41
   
o Cigarette smoking   
o Diet – rich in animal fat   
o Chronic pancreatitis   
o Post Gastrectomy, cholecystectomy   
o Chemical exposure: naphthylamine, benzidine   
o Hereditary: Familial polyposis, Gardener’s syndrome   
o Diabetes mellitus 
 
    d.       Ca head of pancreas  
              Accounts for 60% of periampullary carcinomas. Atleast 2/3 rd of cases 
of pancreatic cancer arises in the head of the gland. Ductal carcinoma of the 
pancreas accounts for more than 90% of all malignant pancreatic exocrine 
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tumours. Other variants are giant cell carcinoma, adenosquamous carcinoma, 
mucinous carcinoma and acinar cell carcinoma.   
             Pancreatic cancer has a propensity for perineural invasion within and 
beyond the gland and for rapid lymphatic spread. The commonest sites for 
extralymphatic   involvement  are the liver, peritoneum and lungs.   
 
e. Carcinoma of Ampulla of Vater  
 
  Accounts for   20% of periampullary  carcinomas. Most are adenocarcinomas. 
Though a number of other tumor histologies  such as  carcinoids, other 
neuroendocrine tumors and  sarcomas may arise. Spread of the tumors is by 
local extension to involve the pancreas and duodenum and metastasis to 
regional lymph node.                              
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                                        CLINICAL FEATURES
44
   
 
Abdominal pain   
            Typically, the pain is felt in the right uppe r quadrant or epigastrium, 
with frequent radiation to the intrascapular area and typically lasts for 30 
minutes to several hours.   
           The pain due to bile duct obstruction is due to distension and increased 
pressure within the bile duct. With cholangitis both the pain and the initial phase 
of fullness and  discomfort are produced at lower intraluminal pressure.    
           It is inflammatory or malignant lesions  spreads to the surface of  the 
liver or gall bladder “somatic” pain results.   
Jaundice   
         Jaundice is the abnormal accumulation of bilirubin in body tissue, which 
occurs when the serum bilirubin level exceeds 50  mol/L. Excess bilirubin, 
causes a yellow tinting to the skin, sclera and mucous membranes. Jaundice is 
important feature of disease in the blood, liver or biliary system.    
Pruritus   
         Pruritus is an important symptom of liver disease. It   lasts longer   than  3  
to  4 weeks regardless of the cause. It tends to be most marked on the 
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extremities, is present less often on the trunk, rarely on the neck and face.  It is 
often more troublesome after a hot bath and at night, when the skin is warm. 
The pruritus of liver disease has been attributed to the high plasma 
concentration of bile salts. 
 
 Nausea, vomiting   
              Nausea and vomiting is often a striking feature in patients with acute 
biliary obstruction but may not be present.   
.   
Anorexia   
           Anorexia is a common symptom of liver disease, particularly in 
jaundiced patients with either hepatocellular failure or biliary obstruction. 
Anorexia may be profound. Weight loss is probably due to anorexia and 
reduced food intake.   
Bowel functions   
         A moderately increase in stool frequency w ith passage of soft or  loose 
stools due to  increased fecal fat resulting from a lowered intraluminal 
concentration of bile salts. It is an uncommon presenting symptom except in 
malignant biliary obstruction – steatorrhoea occurs  with biliary obstruction but 
much  higher level of fecal fat results when pancreatic duct is  blocked.   
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Stools and urine   
             Fecal colour gives a good indication whether cholestasis is total, 
intermittent or decreasing. Occult blood in stools – sign of malignancy.   
             Bile salts, deficient in the intestine in cholestasis are essential for the 
normal colour of the stools. It is usually pale in colour in cholestasis.   
             Urine is dark in colour in cholestatic   jaundice because of increase in 
circulating conjugated bilirubin. 
              Mass per abdomen – Gall bladder palpable or   Courvoisier’s gall 
bladder.   
Bleeding   
        Patients may complain of spontaneous bleeding from the nose and gums or 
of easy bruising, because the prothrombin time   is prolonged due to decrease in                
vitamin K   absorption.   
 
Fever   
       This is secondary to acute cholangitis, which results from two factors, 
obstruction of the biliary tree and bacteria in bile.   
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General Physical Examination   
 
 A parous middle-aged obese female is a candidate for gallstones while 
chances for  cancerous biliary obstruction increases with age 
. 
 Widely set eyes, a prominent forehead, flat nose and small chin are 
features of any form of persistent intrahepatic cholestasis in childhood 
. 
 Xanthoma and Xanthelesma around the eyes suggests chronic cholestasis. 
Elevated plasma cholesterol levels are seen as de posits in palmar creases, 
below the breast, chest or back. The tuberous lesions appear later and are 
found on extensor surfaces, especially the wrists, elbows, knees, ankles 
and buttocks. 
  Fever may be present in metastatic liver  disease and with primary 
carcinoma of  pancreas and stomach.   
  Dyspnoea and tachypnoea is commonly seen due  to ascitis, abdominal 
organomegaly  due to elevated and restricted movement of the 
diaphragm.    
  Jaundice: Yellowish discolouration of sclera, skin and mucous 
membrane due to increase in serum bilirubin above 2 mg/dl.  Patients 
with prolonged biliary obstruction have a deep greenish hue compared 
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with hemolytic jaundice where it is mild yellow and in hepatocellular 
jaundice where it is orange.  
  An increase in melanin pigmentation is seen with many chronic liver 
disease and chronic cholestatic disorders.   
  Scratch marks result from severe pruritus.   
  Spider naevi, excessive bruising, tiny petechial haemorrhages indicates 
the presence of chronic liver diseases.   
 
                                           INVESTIGATIONS   
 Laboratory Examinations 
44-46
 
 
1.     Urine bilirubin   
        When bilirubinuria is present the urine is unusually dark brown in colour. 
Test strips can detect as little as 1 to 2   µmol of bilirubin per litre. Bilirubinuria 
occurs even with small  increase in plasma-conjugated bilirubin and usually 
precedes jaundice.   
 Absence of bilirubinuria is important in a jaundiced patient, as it suggests an 
unconjugated hyperbilirubinemia or hemolysis.   
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2.  Urinary Urobilinogen    
      Bilirubin esters entering the intestine undergo bacterial hydrolysis and 
degradation in the ileum and colon with the production of urobilinogen. Normal 
levels in the stools – 40 to 200 mg/24 hrs.   
       Urinary urobilinogen give a reaction with Ehlirich’s aldehyde reagent. A 
normal value is 0 to 4 mg/24 hrs.   
        In the presence of liver damage more urobilinogen escapes hepatic uptake 
and biliary excretion and it is excreted in urine. 
3.  Liver Function Tests   
a.    Serum bilirubin   
       Normal values:  Total     -   upto 1.2 mg/100 ml   
                                  Direct   -    upto 0.4 mg/100 ml   
                                  Indirect    - 0.4 to 0.8 mg/100 ml   
 
            The standard test for bilirubin is the Vandenberg reaction. The basis for 
this colorimetric test is the differing solubility of conjugated and unconjugated 
bilirubin.   
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            Hepatocellular disease impairs excretory function of bile to a greater 
degree than the ability to conjugate bilirubin and therefore the 
hyperbilirubinemia in this setting is predominantly of the conjugated type. It   is 
very difficult to distinguish between hepatocellular disease and extrahepatic 
biliary obstruction solely on the basis of conjugated   hyperbilirubinemia.   
             In patients with jaundice secondary to extr ahepatic obstruction, the 
determination of the direct fraction of bilirubin is more sensitive index than total 
bilirubin.   
b. Alkaline Phosphatase   
 Normal – 3 to 13 King Armstrong (K-A) units (Or)   
                 1.5 to 4 Bobansky units (or)   
                 35 – 130 IU/L   
 
  The level of alkaline phosphate rises in cholestasis and to a lesser extent when 
liver cells are damaged. The rise in alkaline phosphatase along with increase in 
Gamma glutamyl  transpeptidase is specific for hepatobiliary origin 
c. Gamma Glutamyl Transpeptidase   
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             Serum values are increased in cholestasis and hepatocellular diseases. 
Levels parallel to serum alkaline phosphatase in cholestasis and may be used to 
confirm that a raised serum phosphatase is of hepatobiliary origin.   
d. Aminotransferases   
1.  Serum Glutamic Oxaloacetic Transaminase (SGOT) or Aspartate 
Transaminase (AST) 
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        This is a mitochondrial enzyme present in  large quantities in heart, liver, 
skeletal  muscles and kidney and the serum level increases whenever these 
tissues are acutely destroyed, presumably due to release from damaged cells.   
Normal:       SGOT: 6-40 units (Karmen)    
                                 5-40 IU/ml   
                                 0-15 IM/ml   
2.  Serum Glutamic Pyruvic Transaminase (SGPT) or Alanine 
Transaminase (ALT)   
      This is a cytosolic enzyme also present in liver. Compar ed to SGOT major 
amount is present in liver. Therefore, this is more specific for liver damage than 
SGOT.   Normal:           SGPT: 6-36 units (Karmen)   
                                                  0-15 IM/ml   
                                                  5-35 IU/L   
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  3.  Albumin:   Normal – 35 to 50 g/L   
      Synthesized in the hepatocytes.  Its half-life is 15 to 20 days. 
Hypoalbuminaemia reflects severe liver damage and decrease albumin 
synthesis. Other causes for   hypoalbuminaemia are:   
 Protein losing enteropathies   
 Nephrotic syndrome   
 Chronic infection   
4.  Globulin:  Normal – 5 to 15 g/L   
       They are a group of protein mostly ma de up of gamma globulin, produced 
by B- lymphocytes. Alpha and beta globulin are produced in hepatocytes. 
Globulin increases in  chronic liver disease.   
5.  A/G ratio:  1.5-3/1. Any change or reversal in the ratio indicates                              
liver damage.   
6.  Prothrombin time:  Normal – 12 to 16 seconds which collectively measures 
factors II, V, VII, and X. Biosynthesis of these depends on Vitamin K, 
Prothrombin time may be elevated in hepatitis, cirrhosis and obstructive 
jaundice. Marked prolongation of prothrombin time > 5 sec above control is a 
poor prognostic factor.   
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Radiological studies
47-51 
 
 
1.    Ultrasound   
       Ultrasound examination of the hepatobiliary system is an important first 
line, non- invasive investigation. Patient preparation for ultrasound should 
include fasting for 12 hours.  Dilated bile ducts, gall bladder disease, hepatic 
tumours and some diffuse hepatic abnormality are identified.
48,49
   
       Normal ultrasound shows the liver to have mixed echogenicity. Portal and 
hepatic veins, inferior venacava and aorta are shown. Normal intrahepatic ducts 
measuring 1 to 3 mm in diameter and common bile duct 2 to 7 mm in diameter 
are seen on ultrasound.   
    Ultrasound plays a vital role in the evaluation of focal liver disease, screening 
for liver metastasis, hepatocellular carcinoma, portal hypertension, surgical  
obstructive  jaundice  and hepatic  veno-occlusive disease.   
             Sonography is ideally suited to study the internal architecture of a focal 
mass and distinguish a solid from a cystic lesion. The addition of colour 
Doppler flow imaging further helps in characterizing mass lesions and assessing 
patency of vessels.   
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              The major drawback of this technique is that it is highly operator 
dependent.   
 
2.  Computed Tomography (CT)   
        CT also shows dilated bile ducts distinguishing obstructive from non-
obstructive   jaundice in 90% of cases. But as a screening procedure it has no 
advantage over ultrasound.  It is however, more likely than ultrasound to show 
the level and cause of obstruction.   
      Advancement of CT technology including the development spiral scanners 
and more recently, multi-detector row CT scanners and  the development of 
three dimensional (3D)  imaging software have significantly improved  the 
ability of CT to image patients with  obstructive biliopathy
.52
   
 
3.  Endoscopic retrograde cholangiopancreatography (ERCP)   
     With the help of ERCP, diseases of  the oesophagus, stomach, duodenum, 
pancreas  and  the biliary tract including duodenal diverticula and fistulae may 
be diagnosed.
53
   
    ERCP is performed with a side viewing   endoscope, either video or fibre-
optic. The  stomach and duodenum are inspected and biopsy  and cytology 
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specimen taken if indicated.  The papilla is identified. The cannula is  then  
introduced under direct vision into the papilla  and contrast injected under 
fluoroscopic control. X-ray films are taken. The success rate of    ERCP is 80 to 
90%, but depends on experience
.54
   
Indication   
o Used to show duct strictures   
o Gall bladder and common bile duct stones   
o Pancreatic and bile juice may be obtained for culture, aspiration 
cytology   
o After biliary surgery   
o Pancreatic disease   
o Cytology or biopsy from malignant growth or strictures   
 
Complication   
 Acute pancreatitis   
 Cholangitis    
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4.  Percutaneous transhepatic cholangiography   
     Contrast is injected percutaneously into a bile duct within the liver. The 
procedure is done in the radiology department. The “skinny” chiba needle is 22 
G, is introduced in the 7th, 8th, or 9th right intercostal space at mid axillary line, 
with the help of USG & the contrast is injected. Biliary tree is identified and if 
any dilated ducts are encountered, they should be catheterized and external or 
internal biliary drainage established.
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       The technique is easy and the success rate is 100% if intrahepatic bile ducts 
are  dilated.   
 
Indications  
 When ERCP has failed.   
 Endoscopic access is difficult (Hepaticoenterostomy, Billroth II).   
 Brush cytology and biliary biopsy may be performed.   
 
    Complication   
 Bleeding   
 Biliary peritonitis   
 Septicaemia   
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  5.  Magnetic resonance cholangiopancreatography (MRCP)  
       MRCP shows water containing bile and pancreatic juice within bile duct 
and pancreatic duct without the need for injection of contrast. MRCP is more 
expensive than  USG and CT, and is not available in all hospital.   
     It has an overall accuracy of greater th an 90% in showing common bile duct 
stones.  Highly accurate in showing bile duct stricture and pancreatic 
carcinoma.   
 
    6.  Endoscopic ultrasound (EU)  
 
            This is done using an endoscope which has a miniature ultrasound 
transducer mounted at its tip. Most endoscopes used for ultrasonography have a 
mechanical rotating   scanner at the tip and are side or oblique viewing. 
Recognizing the structures seen at endoscopic ultrasonography requires a 
sufficient   period at training and this has limited its  general availability to 
specialist  centres.   
        In the hepatobiliary system its prominent role is in the detection and 
evaluation of pancreatic tumours. It also detects common bile duct stones and 
can be used for image- directed biopsy. Accuracy of endoscopic ultrasound for 
choledocholithiasis is greater than  90% 
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.   
7.  Biliary scintigraphy
59 
  
           The technetium-labelled iminodiacetic acid  derivative (IDA) is cleared 
from the  plasma by hepatocellular organic anion transport and excreted in the 
bile.  The method may be used to determine patency of the cystic duct in 
suspected acute cholecystitis. The gall bladder ejection fraction can be 
calculated. Cholescintigraphy can show whether the bile duct is obstructed. 
Scintigraphy is also useful in assessing the patency of biliary- enteric  
anastomosis and may show biliary leaks after cholecystectomy or liver 
transplantation.   
 
  8.  Operative and postoperative cholangiography  
         They are indicated when there is stones present in common bile duct. 
After exploration of the common bile duct, cholangiography should always be 
performed, using   high kilovolt peak technique and full strength contrast.   
         Any debris may cause filling defects less sharply defined than those 
caused by gallstones. Any obstruction of the common bile duct, there will be no 
flow contrast into the duodenum.  
        Postoperative cholangiography using contrast injected gently should be 
undertaken routinely before final removal of  a T-tube draining the biliary tree. 
61 
 
It is essential to obtain filling of all right and left intrahepatic radicals, the 
common hepatic duct and common bile duct and flow to duodenum before 
removal of T-tube.   
.   
9. Abdominal Radiograph    
          The abdominal radiograph may be performed as  part of the initial  
surgical evaluation  of the patient presenting with an abdominal condition.    
o 10 to 15% of gallstones will be visualized by this examination.   
o Gas in biliary tree (Aerobilia) may be seen after  endoscopic  
sphincterotomy or  surgical bile duct or bowel anastomosis.   
 
10.  Barium contrast upper gastrointestinal X-ray   
   X-rays can distinguish between a neoplastic and calculus obstruction. Early 
changes in malignancy include short thick mucosal folds in duodenum  with  
relative stasis. The circumscribed filling defect in the gastric silhouette 
described as PAD SIGN, the post-bulbar impression of duodenum due to a 
dilated common duct in Ca pancreas. The reversed “3 sign” of Frostberg in 
periampullary carcinoma are all important radiological signs of malignancy.   
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11.  Oral Cholecystography   
      Agent used usually is Iopanoic acid. The material is transported in the blood 
bound to albumin and selectively taken up by the liver, where it is conjugated 
and excreted as the glucuronide of Iopanoic acid.  The contrast material then 
enters the gall bladder and is concentrated there. Gallstones detected in most of 
the patients and anomalies of gallbladder visualized.   
   Non-visualization of gall bladder has numerous causes including failure to 
ingest the  agent, intestinal obstruction preventing passage through the small 
bowel, malabsorption, liver  dysfunction and biliary tract abnormalities 
preventing flow of contrast into the gall bladder.   
12.  Intravenous cholangiography   
       From the time of its development in 1953 until recently, intravenous 
cholangiography using sodium or meglumine  iodipamide  has been regarded as 
an important technology for  examination of the biliary tree. It has been reported 
that the common duct will be visualized in 90% of patients with normal levels 
of bilirubin. Problems with this procedure include faint visualization, morbidity 
and mortality associated with the contrast agent and non- visualization in the 
jaundiced patient.   
     Despite these problems, it has been a widely used procedure especially for 
evaluating the patient who has undergone cholecystectomy for biliary leak.   
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    As the error rate is rather high and there are other imaging technique that 
offer better visualization of biliary tree the value of intravenous 
cholangiography is doubtful.   
 
Preoperative preparation   
 Obesity increases the technical difficulties for the surgeon and makes 
post-operative complications more likely.  Weight reduction under the 
control of dietician if possible.   
 Use of contraceptive pills adds the risk of venous thrombosis and it is 
advisable that OCP   be stopped prior to and after 6 weeks of surgery.   
 An abnormal prothrombin activity increases the risk of haemorrhage. 
Administration of Vitamin K dose will reduce this risk.   
 Pre-operative antibiotic prophylactic is given.   
 Insertion of Nasogastric tube, intravenous fluid infusion and urinary 
catheter to monitor output is a must.   
 The patient’s blood grouping in case of transfusion is necessary.   
 Nutritional status should be assessed and improved if necessary.   
 The renal, cardiovascular system and CNS should be evaluated before 
surgery.   
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 Jaundice patient have a high-risk of postoperative renal failure which can 
be reduced by operating during diuresis produced by Mannitol with fluid 
supplementation.    
 
   
Anaesthesia   
      General anaesthesia for biliary tract  surgery  is essentially no different from 
that of  any  intraabdominal operation. However, there are a few points  of  
particular  interest to the  anaesthetist.   
 The presence of abnormal liver function test s requires caution to be taken 
according to the degree of abnormality with the dosage of all drugs used, 
as almost all depend on the  liver  for  their  detoxication.  Halothane   is 
contraindicated in the presence of abnormal liver function.  
 General anaesthesia must produce sleep, analgesic, good muscle 
relaxation and stable blood pressure.   
 Care must also be taken during the operation to avoid kinking of inferior 
vena cava   during deep retraction which results in drop in cardiac output.   
 Intravenous atropine 0.6 mg given first before the operative 
cholangiogram helps to diminish any spasm of the sphincter of oddi.   
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Position of patient   
 
  Patient is placed on the cassette table top. Patient is placed supine with a foam 
pillow is inserted under the ankles to raise the calves off the table. Another 
foam pillow is inserted at back of the patient to elevate the gall bladder bed.   
Incision   
   
 Kocher’s right subcostal   
 Midline incision   
 Right upper paramedian   
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    Surgical procedures   
 
  In current surgical practice, various operative procedures have been performed 
for obstructive jaundice, depending on the cause. The choice of procedure also 
depends on the experience and preference of the surgeon.   
 Cholecystectomy with common bile duct exploration with stone  
 Removal/dilatation/ sphincteroplasty and T-tube drainage.   
 Cholecystectomy with   Choledochoduodenectomy with T-tube drainage.                                     
 Cholecystojejunostomy 
 Pancreaticoduodenectomy (Whipple’s procedure)   
 Palliative operation for relieving obstructive jaundice due to malignant 
disease.   
 Pancreaticojejunostomy   
 Non-surgical biliary drainage   
 Different operations for biliary stricture   
A.  Exploration of the common bile duct 
61 ,62
  
      The operation of choledochotomy carries a mortality of atleast four times 
greater than cholecystectomy alone.   
Indications   
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 History of jaundice   
 Multiple small stones or Single faceted stone in the gall bladder   
 A dilated cystic duct   
 Induration of head of the pancreas   
 Dilated common duct – more than 8 mm   
 A  palpable stone in the common bile duct during surgery.   
Operation   
Opening of the duct   
Stay sutures of catgut are inserted  into  the common duct near either side of the  
anterior aspect about 2 cm above the first part of the duodenum and a 
longitudinal incision is  made with a fine knife.  
Exploration (Distal)   
 
        Fogarty catheter is inserted down the common bile duct into the duodenum 
and the balloon inflated. The catheter is gently withdrawn  until  it  is  halted  by  
the  sphincter of Oddi.  The lower end of the duct is palpated and stone felt 
against the catheter, above the balloon. A bulldog clamp is placed across the 
common duct above the opening to prevent any stones escaping into the 
proximal ducts. The balloon is deflated and the catheter gently brought through 
the sphincter this can be traced by the palpating fingers. The  balloon  is  
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reflated  and  steadily withdrawn bringing the stone with it. This procedure is 
repeated until no more stones   are withdrawn. 
   
 
Exploration (Proximal) 
   
   The catheter is reinserted into the proximal segment and the procedure is 
repeated in the left and right hepatic ducts. The bulldog clip is placed on the 
common duct below the opening to prevent stones falling into the distal duct. 
The balloon is inflated  until  some  resistance is felt and withdrawn with the 
pressure maintained on the syringe. This is necessary because the lumen of the 
duct increases in diameter and unless the balloon continues to fill the lumen, a 
stone may slip past.  
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 Assessment by X-ray   
     The catheter is inserted into the common duct so that the balloon lies just 
distal to the opening where it is initiated to occlude the duct. After checking th e 
position of the x-ray machine, about 10 ml of hypaque is injected an d films are 
taken. The balloon is deflated and the procedure repeated with the catheter in 
the common hepatic duct. For fixed  stone  bougie’s or Desjardin’s forceps are 
used to dislodge the stone and withdrawn.   
      Closure of the duct can be done with or without a T-tube. Catgut is used and 
usually it is continuous.  
     Gall bladder is removed, cystic duct, cystic artery ligatures are checked. Any 
bile leak from the common bile duct is inspected.   
Removal of T-tube postoperatively  
   The t-tube is allowed to drain freely into a bile bag for 5 days when it is 
clipped for 1 hour after meals. This is increased by 1 hour each day so that by 
the tenth day the tube is  clipped all day. A T-tube cholangiogram is obtained a 
final check that the duct system is normal and if so the skin suture is withdrawn 
and the tube removed.   
D.  Sphincterotomy
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      Sphincterotomy   requires  duodenotomy  placed  at  the level of the 
sphincter of Oddi,  division of the sphincter and suture of the  wall of common 
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bile duct  to the duodenum. It has advantages of facilitating inspection of the pa 
pilla, biopsy and pancreatic radiography, if required.   
Indication     
 Common bile duct stone   
 Stricture at the lower end of the common bile duct   
 
   E.  Exploratory choledochoscopy
64
   
 
  The choledoscope  permits visual inspection within the bile ducts during 
surgical  exploration for gallstones and may greatly facilitate the exploration of 
the common and  hepatic bile ducts and the localisation and retrieval of stones.   
 
Position of patient   
            The operating table should have facilities for x-ray to enable the 
operative cholangiography to be done. The patient should be positioned with a 
few degrees of feet down and lateral tilt to the right.   
Incision   
        A transverse  right upper abdominal incision.   
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Operation   
        Once the abdomen is opened, the duodenum and the hepatic flexure of the 
colon are retracted downwards. A clear exposure of  anterior  aspect  of  the 
supraduodenal common bile  duct is done. The choledochotomy should be 
placed as low as possible, above the superior border of the duodenum.   
     The choledochoscope is introduced into the common bile duct in a distal 
direction.  The interior of the common bile duct is inspected as the instrument is 
advanced distally. A gallstone may be retrieved from the common bile duct 
under direct vision. A fine balloon catheter (Fogarty) is passed down the 
channel of the choledochoscope  and  passed  beyond  the  stone and inflated. 
The balloon, stone and instrument all withdrawn together.   
      For multiple mobile stones in the duct are tractable wire basket may be 
passed down the choledochoscope channel. The basket should be used to open 
as a dragnet to avoid crushing of the stones.   
           Proximal choledochoscopy is done to view hepatic ducts. 
Choledochotomy is closed with 3/0 catgut, either interrupted or continuous.   
 
  F. Transduodenal exploration of the bile duct (Biliary Sphincterotomy)
63  
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Indication   
 Impacted stone to the lower end of the common bile duct.   
 Stenosis of the papilla and sphincter  
 Re-exploration   
Contraindication   
o A single large stone in the supraduodenal portion of the common 
bile duct that does not descend to the sphincteric region.   
o Multiple facetted stones locked in the bile duct.   
 Long stricture of terminal common bile duct   
 Presence of acute pancreatitis.   
 
     Operation   
             Either a right paramedian  or  Kocher’s  subcostal incision provides 
good access to the  biliary tree once the abdomen is opened, the  hepatic flexure 
of the colon and proximal  transverse colon are mobilized and reflected caudally 
exposing the head of the pancreas and  the duodenal.   
            Head of the pancreas and duodenum are mobilized forward and 
medially. Dissection continues until the aorta is visualized and the third part of 
the duodenum is free. Papilla is located on the medial wall of the duodenum. A 
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small bulldog clip is then placed across the supraduodenal part of the common 
bile duct in order to prevent calculi slipping back into the common hepatic duct 
and its tributaries.   
 The duodenal walls are incised longitudinally or transversely. Babcock tissue 
forceps are applied to the longitudinal fold, distal to the papilla and the latter is 
drawn into duodenotomy incision. A grooved director or lacrimal probe is 
passed into the papillary orifice and hence into the common bile duct.   
        Sphincterotomy is done at 10’0 clock position. Stones are extracted with 
Desjardins forceps and Fogarty balloon catheters. Clearance of the duct is 
confirmed by intraoperative post-exploratory cholangiography.   
        Alternatively, choledochoscopy may be used. The duodenotomy is closed 
in its original axis using a continuous suture (catgut) and fine non-absorbable 
Lambert suture.   
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Complication     
         Bleeding: Persistent bleeding of the sphincterotomy incision usually 
occurs from a divided circumferential duodenal artery which is best secured by 
suture.   
        Cholangitis: It is important to remove all calculi and provide an adequate   
sphincterotomy with free drainage.   
        Acute pancreatitis: Probing into pancreatic duct should be avoided and to 
ensure that  no suture encircle the pancreatic duct.   
 
G.  Duodenoscopic sphincterotomy for removal of duct stones
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             Fibreoptic oesophagogastroduodenoscopy is now a routine procedure. 
ERCP is performed by passing a Teflon catheter through the biopsy channel of 
the duodenoscope and placing it directly in the orifice of the papilla of vater 
under direct vision. Contrast material is then injected during fluoroscopy and 
appropriate radiographs are ta ken. The technique is performed under sedation.   
 
Sphincterotomy    
         After endoscopic cholangiogram has demonstrated stones, the Teflon 
catheter is replaced in the distal bile duct by a diathermy wire.   
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         After confirming its position radiographically the wire is withdrawn 
slightly and made taut to produce a bow, pressing on the root of the papilla.   
         Diathermy current is applied to produce a cut 15-20 mm long. The aim is 
to ablate the biliary sphincters and a view directly up the bile duct is obtained.   
 
                  
 
  Stone extraction    
              After sphincterotomy, some allow stones to pass spontaneously (< 1 
cm in diameter).  Few prefer to remove all stones using balloon catheters or 
wire basket.   
Complication    
 Bleeding (mainly from the sphincterotomy site)   
 Cholangitis   
 Pancreatitis   
 Retroperitoneal perforation   
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Endoscopic treatment for patients without stones   
       Patient with convincing biliary symptoms following biliary surgery are 
suspected to have sphincter of Oddi dysfunction or stenosis; this may result 
from the passage of stones or instrumentation.   
       Endoscopical sphincterotomy is a logical and effective form of treatment 
when functional obstruction is present.   
      For malignant biliary obstruction, when the patient unfit or unsuitable for 
surgery, jaundice can be relieved by performing sphincterotomy through the 
tumour or by placing a prosthetic stent.   
 
Palliative operations for jaundice due to malignant disease
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Indications   
Non-resectable carcinoma of the pancreas and peri-ampullary carcinoma   
        Two symptoms are readily palliated by operation: duodenal obstruction 
and jaundice.   
       For duodenal obstruction gastroenterostomy with entero-enterostomy is 
done.   
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For jaundice   
 
a.   Cholecysto-enterostomy   
      Indication: Tumour must  atleast be 5 cms below the junction between the 
cystic  duct and the common bile duct.   
    Procedure   
o Gall bladder emptied using a trocar suction apparatus. 
   Jejunal loop is laid alongside the gall  bladder of cholecyst oenterostomy 
done  using 2/0 catgut.    
  b. Choledochojejunostomy   
Indication   
 Distal common bile duct malignant stricture   
 Malignant growth distal common bile duct/ Peri-ampullary carcinoma   
End-to-side anastomosis   
              The common duct is dissected free and transected, and the distal end is 
oversewn.  The proximal end is then sutured to the loop of jejunum. The 
opening in the jejunal loop, made at the apex should be a little smaller than the 
diameter of the common duct.    
78 
 
    Anastomosis can be completed with or without T-tube.   
 
Side-to-side anastomosis   
          If the bulk of the jejunum a llows, then a series of accu rate interrupted all 
coats  sutures is placed between the opening of the common duct and the 
opening in the jejunum. Anastomosis completed with or without T-tube.  
   
 C.  Choledochoduodenostomy
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Indication   
 Dilated common bile duct containing infected bile and biliary sludge.   
 Multiple intrahepatic stones   
 Suppurative cholangiohepatitis   
Contraindication   
 In patient with a bile duct of normal dimension.   
 
Operation   
         Incision: Kocher or Paramedian   
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         Exposure: First and second parts of duodenum with addition of the lesser 
sac and the free edge of the lesser omentum and the liver.       
  Dissection   
                The common bile duct is then opened and a specimen of bile sent for 
culture. Stones are removed and the duct is cleared by copious lavage with 
saline. The duodenum is freely mobilized by Kocher’s maneuver in order to 
allow it to roll upwards over the anterior surface of the bile duct.  
           
       After the duct has been dissected a vertical incision 2-5 cm long is made on 
its supraduodenal portion and the duodenum is opened  in such a way to allow 
the stoma to be  made without tension. The anastomosis is done with interrupted 
3/0 chromic catgut.  
  
 
I.   Benign biliary stricture
70
  
Diagnosis and Principles of treatment   
            Damage to the bile duct may be recognized immediately (at operation), 
early postoperative period or late after discharge.   
Immediate repair of bile duct injury   
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           The form of repair will depend upon the se verity and site of the damage, 
but results are excellent.   
a.    Common duct laceration without tissue loss   
       Insertion of T-tube through the laceration and closure of the wound with 
interrupted absorbable sutures. T-tube is removed after 10 days, after 
cholangiogram.   
b. Common duct laceration with minimum tissue loss   
     Loss of part of the wall of common duct occurs when the cystic duct is torn 
at its origin. Its tissue loss is minimal; the edges are trimmed and closed 
transversely. T-tube is positioned in common bile duct through a separate 
incision and removed after four weeks.   
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End-to-end anastomosis   
         A clear division of common duct without tissue loss may be repaired by 
direct anastomosis at the two ends with interrupted sutures over a T-tube, which 
should be left in situ for three months.   
Biliary intestinal anastomosis        
         Accidental removal of a whole segment of common bile duct will 
necessitate some form of biliary-intestinal anastomosis using a Roux loop at 
jejunum.   
Late repair of bile duct stricture   
1.  Biliary intestinal anastomosis for low bile duct strictures   
     Treatment of a stricture at the lower end of the common bile duct will 
depend upon its site and relationship to the ampulla.   
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a. Choledochoduodenostomy   
      To avoid leaving an undrained sump the common duct above the stricture is 
anastomosed side-to-side to the second part of the duodenum establishing a 
wide stoma. 
b.   Choledochojejunostomy   
      Anastomosis of the common duct to a jejunal Roux-en-Y is theoretically 
more desirable because food particles are less likely to enter biliary tree and 
obstruct its lumen.   
 
  Biliary intestinal anastomosis for mid duct strictures   
           Anastomosis of dilated common hepatic duct above the stricture to a 
jejunal Roux-en-Y loop using interrupted catgut.  A T-tube inserted into the 
common hepatic duct with one arm through the anastomosis should remain in 
situ for three months.  
Biliary-intestinal anastomosis for high duct stricture   
 The track, which will lead to the mucosa-lined ducts, is first explored 
with a fine probe , it is then enlarged with Baker’s dilators.   
83 
 
 Once a mucosa-lined duct has been identified a rubber catheter is 
positioned and cholangiogram performed. This will demonstrate 
anatomy, degree of dilatation and any stones present.   
 Positioning of a transhepatic tube: Fully curved Randall’s forceps are now 
inserted  into the common hepatic ducts and passed along the dilated 
intrahepatic duct system,  usually of the left lobe and then to the periphery. 
Then tip of forceps grasp the end of the latex rubber tube and is drawn along the 
ducts to appear at the porta hepatitis.   
 Construction of Roux loop and exposure of the jejunal mucosa:  
 A standard ante- colic jejunal Roux-en-Y is fashioned and the end 
of the free limb closed in two layers.  Just proximal to this closed 
end a 2 cm diameter disc of seromuscular wall is removed to 
expose the intact jejunal mucosa.   
 The end of the transhepatic tube passed to the jejunal lumen and 
anchored.   
 Traction on the transhepatic tube from above will draw the mucosa, 
into the lumen of the common duct to create sutureless anastomosis 
with mucosa-to-mucosa opposition.   
 Few interrupted catgut sutures are inserted between the jejunal 
serosa and liver capsule to maintain the graft in position.   
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 The upper end of the transhepatic tube is brought out through a 
separate stab incision in the abdominal wall and fixed securely to 
the skin with non-absorbable suture.   
 
Bilateral mucosal grafts    
       For very high stricture involve the carina or the right and left ducts 
individually. In this event both ducts intubated and the transhepatic tubes 
inserted separately through the exposed jejunal mucosa to create an epithelial 
bridge between the two ducts.   
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  Management of the transhepatic tube and vacuum drain   
 
 First 3 postoperative days – low-pressure suction (Robert’s pump at 5 cm 
Hg).   
 Later replaced by plastic bag into which bile drains freely.   
 On the tenth day cholangiogram to confirm patency of the  anastomosis.   
 End of the transhepatic duct closed with a spigot.   
 Patients are taught to irrigate the tube daily with 20 ml  sterile water to 
maintain  patency.   
 Three months later the transhepatic tube is removed.   
 
J.  Alternative methods of biliary decompression   
1.  Intrahepatic cholangiojejunostomy (long wire operation): Involves the 
anastomosis of an exposed peripheral intrahepatic duct to a defunctional limb of 
jejunum.   
2.  Percutaneous transhepatic drainage.   
 
Malignant biliary stricture
70
   
Proximal tumours   
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 Hepatic bifurcation tumours   
 Hepatic duct tumours   
a. Parts to be excised are (radical excision)   
 Gall bladder   
 Entire supraduodenal common hepatic duct system as far as the right and   
left hepatic ducts.   
b. Join the several hepatic duct openings  for two biliary enteric anastomosis   
c. Silastic drains through the substance of liver is brought to the inferior surface                  
of the liver.   
d. Roux-en-Y loop is constructed and sutured to the jejunum with silastic tube 
inside (internal) and the other end brought outside the abdominal wall. The 
tubes are removed after 2-3 months after cholangiogram.   
Distal tumours   
              Tumours of the bile duct below the cystic duct are treated with  
pancreaticoduodenectomy.   
o Whipple’s surgery   
o Pylorus preserving pancreaticoduodenectomy   
o Total pancreatectomy   
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Non-surgical biliary drainage   
 External drainage    
 Internal drainage   
External drainage   
Indications   
 Drainage done preoperatively to reduce ope rative mortality and 
morbidity, especially acute renal failure.   
 Incase of acute cholangitis because later surgery is expected to be safer.   
 For patients who are inoperable, long term drainage being performed to 
relieve symptoms of cholestasis.   
Prerequisite   
    Intrahepatic ducts have to be dilated.   
    Coagulation studies should be normal.   
    Lateral X-ray screening facilities available.   
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Procedure   
          As per percutaneous transhepatic cholangiogram and then a stent is left  
(j=shaped/pig-tailed catheter placed) for decompression.   
            
Internal drainage   
 ERCP and stenting – explained earlier.   
 PTC where the guide wire is passed beyond the stricture and then the 
stent passed. After the insertion of the stent through the stricture, guide 
wire removed allowing internal decompression of the cholestasis.   
 Palliative operation for jaundice due to malignant disease  
 
Pancreatoduodenectomy (Whipple’s Operation)   
       The purpose of the operation of pancreatoduodenectomy is to remove the 
tumour en bloc with adjacent lymph nodes. The head of the pancreas, the 
duodenum, the pylorus and distal half of stomach, the gallbladder and th e lower 
end of the common duct and to restore  biliary-pancreatic and gastrointestinal 
continuity.   
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       Pancreatoduodenectomy is the treatment of  choice for operable malignant 
tumours of  the ampulla of vater, the lower end of  the common bile duct, the 
duodenum and the  periampullary region of the head of the pancreas.   
 
Incision   
 Right Mayo-Robson   
 Bilateral subcostal incision   
 
Procedure   
I.  Retraction of common bile duct: Exposure and ligation of right gastric and   
gastroduodenal arteries.   
II. Finger dissection between pancreas and portal vein from above and finger 
dissection between pancreas and superior mesenteric vein from below. If both 
index finger meet, lifting the pancreas forward and then resection can be carried 
out.   
III. Division of stomach (Partial gastrectomy).   
IV. Division of common bile duct with the gallbladder.   
V.  Division of the pancreas in front of the portal vein.   
90 
 
VI. Division and mobilization of the jejunum.  
VII. Detachment of duodenum and uncinated process of pancreas from superior 
mesentric vessels.   
VIII. Anastomosis of bile duct to jejunum. Anastomosis of pancreas to jejunum  
gastrojejunostomy.   
 
   
Complication   
 
  Disruption of pancreatojejunal anastomosis.   
 
  Postoperative hemorrhage from gastrointestinal tract.   
Pylorus – Preserving Pancreatoduodenectomy   
          A modification to Whipple’s surgery is by preserving stomach and 
pylorus. The duodenum is transected, usually 3 x 4 cm distal to the pylorus  and 
re-anastomosed to the  jejunum at the point where a gastrojejunostomy  would 
have been do ne in the standard  operation. The remaining aspects of the 
procedure are no different.   
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                                           METHODOLOGY   
 
Source of Data   
     Patients admitted to the institute of General Surgery at the Rajiv Gandhi 
government general Hospital, Chennai were taken up for the study. Numbers of 
cases studied were 50 from    
 
Method of Collection of Data   
             After admission to RGGGH, a detail ed clinical history and examination 
of the patient was done. Relevant investigations were undertaken to make a 
diagnosis. Patients were assessed preoperatively for the fitness for surgery and 
later subjected to curative or palliative surgery depending on the stage of the 
disease and general condition of the patient. The resected tissue was subjected 
to histopathological examination.  Postoperatively, patients’ condition was 
assessed and complications were documented.  Photographic documentation has 
been done wherever possible.    
Inclusion criteria   
     Age – More than 12 years.   
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    Patients proved to have obstructive jaundice by any investigative modality 
during the study period from April 2004 to March 2005.   
Exclusion criteria   
 Age less than 12 years   
 Medical jaundice   
 Cases of obstructive jaundice who are unfit for interventional treatment 
    
Statistical methods   
    Chi-square and fisher exact test have been used to find the significance of 
proportion of symptoms &signs between benign and malignant cases. Student t 
test has been used to find the significance of mean difference of lab parameters 
between benign and malignant cases. The odds ratio has been used to find the 
strength of relationship between symptoms & signs of benign and malignant 
cases. If p value was <0.05 the probability was considered to be statiscally 
significant.  
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RESULTS AND OBSERVATIONS 
 
 
      A Prospective clinical study consisting of 50 cases of Obstructive jaundice 
was  undertaken to investigate the pattern of clinical presentation & lab 
parameters  to study  the cause of obstructive  jaundice and the different modes 
treatment adopted.   
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AGE AND SEX DISTRIBUTION 
 
   
 
 
 
 
 
 
 
Mean age with SD :  51.72 ( 10.5)  
Mean bilirubin with SD 12.3 ( 8.6)  
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AGE CATEGORY  
FREQUENCY
SEX FREQUENCY PERCENTAGE (%) 
Male  30 60 
Female  20 40 
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PATIENTS PRESENTING WITH  ITCHING AS PRIMARY COMPLAINT 
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Present  17 34 
Absent  33 66 
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PATIENTS PRESENTING WITH JAUNDICE AS PRIMARY COMPLAINT 
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Present  34 68 
Absent  16 32 
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PATIENTS PRESENTING WITH ABDOMINAL PAIN AS PRIMARY 
COMPLAINT 
 
 
Abdominal pain  FREQUENCY PERCENTAGE (%) 
Present  20 40 
Absent  30 60 
 
 
 
 
 
 
 
 
ABDOMINAL PAIN 
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PATIENTS PRESENTING WITH FLATULENT DYSPEPSIA  AS PRIMARY 
COMPLAINT 
 
 
Flatulent dyspepsia  FREQUENCY PERCENTAGE (%) 
Present  14 28 
Absent  36 72 
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PATIENTS PRESENTING WITH LOSS OF WEIGHT / LOSS OF APPETITE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOSS OF APPETITE  / LOSS OF WEIGHT 
Present
Absent
Loss of weight &  
Loss of appetite  
FREQUENCY PERCENTAGE (%) 
Present  14 28 
Absent  36 72 
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                           BILIRUBIN LEVELS OF PATIENTS 
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DIAGNOSIS 
 
 
DIAGNOSIS FREQUENCY PERCENTAGE 
Cholelithiasis with CBDcalculi 27 54 
Periampullary growth 21 42 
Mirizzi syndrome 2 4 
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TREATMENT 
 
TREATMENT  FREQUENCY TREATMENT 
Open cholecystectomy with CDD 29 58 
Whipples operation 18 36 
Triple bypass 3 6 
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DISCUSSION 
Obstructive jaundice is a frequent condition of biliary tract disorders and 
the  evaluation and management of the jaundice  patient is a common problem 
facing the  General Surgeon. While diagnosing a case of  surgical jaundice, a 
thorough history, a  complete physical examination & biochemical  tests are 
necessary. Once diagnosed, the  surgeon should have good knowledge about the 
anatomy of the biliary tree, physiology of  bile metabolism and 
pathophysiological change s occurring in the  liver, secondary to  obstruction, 
various causes of obstruction, different imaging facilities and different  
modalities of treatment.   
  In this study, analysis of the various causes of surgical jaundice & its 
presentation  were done. Investigations were  carried out and different ty pes of 
operative procedures  were conducted. Total number of cases were  50. The 
results were compared with other similar studies done by various authors.   
  The common presentation in a benign condition was pain abdomen and 
flatulent  dyspepsia, whereas in malignant condition it was jaundice, high 
coloured urine, pale stool  & loss of appetite. Most malignant cases had Icterus 
and a  palpable gall bladder when  compared to benign condition.  
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   There were significantly higher values of  total bilirubin, direct Bilirubin and  
alkaline phosphatase in malignant conditions.  It was found that obstructive 
jaundice secondary to  common bile duct stones remains the commonest cause, 
obstructive  jaundice secondary to malignancy was the  second most common 
cause followed by benign stricture.   
 
   USG abdomen was carried out on all patients as a standard imaging technique 
for  investigation on a patient presenting with jaundice. USG was successfully 
used as a cheapest non-invasive tool to  know the cause and  level of obstruction  
in nearly 93% of  the patients (USG was unable to diagnose one benign  CBD 
stricture which was  diagnosed by ERCP). The limitation of this  diagnostic test 
was its high operator dependence.   
  ERCP: Its value is its ability to remove stones, stenting and also taking tissue 
for  HPE. ERCP is also one of the diagnostic tools used for surgical jaundice.   
  MRCP: It’s a diagnostic test for imaging of biliary tree. Drawback of this  
imaging technique is its inability to remove calculi, stenting or biopsy tissue for 
HPE.   
  CT scan was also used in selected cases to confirm the diagnosis made on 
USG. Patient with obstructive jaundice due  to CBD calculi underwent 
Cholecystectomy  with CBD exploration with either T-tube dr ainage after 
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intraoperative cholangiogram  showed normal flow of dye into duo denum with 
no residual calculi or choledochoduodenostomy.   
 
   Definitive procedure done for benign CBD  stricture following 
Cholecystectomy  was Hepatico-Jejunostomy with enteroenterostomy.   
  Obstructive jaundice due to malignanc y, 3underwent palliative procedure and  
18 patients underwent definitive procedure  (Whipple’s procedure). The 
outcome of  palliative procedures was good. Patients were free from jaundice.   
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SUMMARY 
 
50 patients were diagnosed to have su rgical jaundice in the study period 
from july2013 to july 2014. Th e study was conducted at the  institute of 
Surgery. A brief introduction and a hist orical review of biliary  tract has been 
presented with a detailed discussion on the surgical  anatomy, physiology, 
etiopathogenesis, clinical features, investigations and management of surgical 
jaundice. The findings of this study were compared  with those available in 
literature. The results have been represented with tables and graphs for better 
understanding.    
 
 
The findings of the study are as follows:   
 
  1.  The occurrence of surgical jaundice was maximum in the 41-50 year age 
group.   
2.clinical  Icterus was present in 34 patients . Pain abdomen and flatulent 
dyspepsia were more in benign condition whereas jaundice,  clay-coloured 
stools, high coloured urine with itching was more common in malignancy.   
3.  High values of serum Bilirubin & alkaline phosphatase are noted in 
malignancy.   
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4.  USG was the cheapest non-invasive investigation used for diagnosis of 
surgical jaundice.   
5.  Most common cause of obstruction was CBD calculi, followed by 
malignancy, then by benign CBD stricture.   
6.  For CBD calculi, CBD exploration with cholecystectomy and drainage 
procedure was done by T tube or choledochoduodenostom   
7.  For malignancy operative curative pr ocedure was Whipple’s surgery and   
palliative procedure was triple byepass   
8.  Recently increasing reliance of ERCP and MRCP to image biliary tract has 
helped to diagnose the pathology earlier and hence early intervention can be 
initiated.   
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CONCLUSION 
  Common presentation of surgical jaundice is jaundice.   
  Palpable GB indicates the etiology to be malignant.   
  Common cause for surgical jaundice is CBD calculi.   
  USG remains the cheapest, safest and mo st reliable diagnostic tool in the  
management of surgical jaundice.   
  Open exploration of CBD under experienced hands is a good treatment 
modality in the management of obstructive jaundice.   
  In malignancies, early detection and staging and proper selection of the patient 
are  more important to gain benefit from  resection of tumour, whereas late  
presentation and those patients not suitable for resection had good improvement 
in quality of survival with palliative surgery.   
Improving deranged LFT, correction of anaemia and hepatorenal problem 
improves the surgical results (morbidity and mortality).   
 
 
   
BIBLIOGRAPHY   
 
1.  Scharsschmidt GF, Goldberg HI, Schmid R. Approach to the patient with  
cholestatic jaundice. N Engl J Med 1983; 308: 1515-1519.   
 
2.  Kim U. Kahnag, Joel J. Roslyn. Jaundice:  Maingot’s abdominal operations. 
Vol. I   
& II. 10th edition. Singapore: Mc Graw Hill; 2001. pg. 315-336, 1701-2031.   
 
3.  Morgenstern L. A history of choledochotom y. In: Berci G, Cushieri A. Bile 
ducts   
and Bile duct stones, WB Saunders 1997; 2: 3-8.   
 
4.  Wood MD. Presidential a ddress; Eponyms in biliary tract surgery.  Am J 
Surg   
1979; 138: 746-754.   
 
5.  Mulvihill SJ, Debas HT. History of surgery of gastrointestinal tract. In: 
Norton  
JA, Bollinger RR, et al (Eds). Surgery, Basic science and clinical evidence.  
Springer-Velrag 2001; 23: 399-412.   
 
6.  William PL, Warwick R, et al (Eds). Gray’s Anatomy. 38 th ed. NY: 
Churchill   
Livingstone; 1995. p. 1394-96.   
 
7.  Adkins RB, Chapman WC, Reddy VS . Embryology, Anatomy and Surgical   
applications of the extrahepatic biliar y system. In: Skandalakis SE, Flament JB.   
Surgical Anatomy and Embryology. Surg Clin N Am Feb 2000; 80 (1): 363-
374.   
 
8.  Inderbir Singh. Human Embryology, 7th ed. New Delhi: Current. p. 186-
196.    
 
9.  Anne M. R. Agur, Ming J. Lee. Grant’s Anatomy. 10th ed. Philadelphia: 
Lippincot   
William & Wilkins; 1999. p. 613-20.   
 
10.  Erlinger S. Bile secretion.  In: Blumgart LH, et al. Su rgery of the liver and 
the   
biliary tract. 3rd ed. NY: Churchill Livingstone; 2000. 1 (5): 109-20.   
 
  95 
 
11.  Schwartz SI. Gallbladder and extrahepatic  biliary system. In: Schwartz SI, 
Shires   
GT, Spencher FC et al (eds ). Principles of Surgery. 7 th ed. Singapore: Mc 
Graw   
Hill; 1999. 2: 1437-1466.   
 
12.  Guyton C. Textbook of Medical Physiology, 10 th ed. Singapore: Harcourt; 
2000.   
749-52, 800-03.   
 13.  Principles and practice of  Medicine. Osler W. 5 th ed. New York: 
Appleton and   
Co. 1992. p. 569.   
 
14.  Cotran RS, Kumar V, Robbins SL. Robbi ns Pathologic basis of disease. 6 
th ed.   
Philadelphia: WB Saunders; 1999.   
 
15.  Diliberto JP, Marks JW, Schoenfield LJ. Classification and pathogenesis of  
gallstones. In: Braasch JW, Tompkins RK. Surgical disease of the biliary tract 
and   
pancreas. Chicago IL; 1994.   
 
16.  Lordsmith of Marlow, Sheila Sherlock. Su rgery of the gallbladder and bile 
ducts.   
2nd ed. London: Butterworth; 1981.   
 
17.  Saunders KD, Cates JA, Roslyn JJ. Pathogenesis of gallstones. In: Pitt HA. 
The  
Surgical Clinics of North America: Bilia ry tract surgery, Philadelphia, PA: WB   
Saunders 1990; 1197-1216.   
 
18.  Smith Al, Stewart L, Fine R, et al. Gallst ones disease. The clinical 
manifestations   
of infectious stones. Arch Surg 1989; 124: 169-633.   
 
19.  Kaufman HS, Magnuson TH, Lillemoe KD et al. The role of bacteria in  
gallbladder and common duct stone formation. Ann Surg 1989; 209: 584-591.   
 
20.  Khuroo MS, Sarjar SA, Mahajan R. Hepatobiliary and pancreatic ascariasis 
in  
India. Lancet 1990; 335: 1503-6.   
 
  96 
 
21.  Choi BI, Park JH, Kim YI, et al.  Peripheral cholangiocarcinoma and   
clonorchiasis: CT findings. Radiology 1998; 189: 149-153.   
 
22.  Howard ER. Surgery of liver dis ease in childhood. Oxford: Butterworth-  
Heinemann; 1991.   
 
23.  Howard ER. Biliary Atresia. In: Blum gart LH, Fong Y. Surgery of Liver &   
Biliary Tract. 3rd Ed. London: WB Saunders; 2000. p. 853-77.   
 
24.  Chijlwa K, Koga A. Surgical management and long-term follow up of 
patients  
with choledochol cyst. Am J Surg 1993; 165: 238-242.   
 
25.  Lennot JP, et al. Bile Duct Cysts in Adults. Ann of Surg 1998; 228(2):159-
66.   
 
26.  Tondelli P, Schuppisier JP. Papillary ste nosis. In: Blumgart LH, Fong 
Y(eds)   
Surgery of the liver and biliary tract. Edinburgh: Churchill Livingstone; 1998.    
 
27.  Kune GA, Sali A. Benign biliary strictur es. In: The practice of biliary 
surgery. 2 nd   
ed. Oxford: Blackwell Scientific; 1981.   
 
28.  Blumgart LH, Kelley CJ, Benjamin IS.  Benign bile duct stricture following   
cholecystectomy: Critical factors in management. Br J Surg 1984; 71: 836.   
 
29.  Blumgart LH. Bile duct injuries/stricture. In: Fromm D (ed) 
Gastrointestinal  
Surgery Vol. 2, London: Churchill Livingstone; 1984. p. 755.   
 
30.  Smith R. Obstructions of the bile ducts. Br J Surg 1979; 69: 317.     
 
 
 
 
 
 
 
 
 
 
 
PROFORMA 
 
CLINICAL STUDY AND MANAGEMENT OF OBSTRUCTIVE JAUNDICE   
 
   
1.  Name:        Age :        Sex :    
2.  Address:                 IP. No:   
3.  DOA:          DOO:       DOD :   
4.  Occupation:   
5.  Chief complaints:   
6.  History of Present Illness:    
A.  Pain.       B. Flatulent Dyspepsia   C.Jaundice  D.itching 
 Duration:   
 Mode of onset:        
  Belching:   
  Heart Burn:      
 
 Clay-coloured urine   
  
 Nausea/ vomiting   
 
 Duration:     Character:   
 
 Relation to food:         
    Relieving factors        Relation with pain:     
High coloured urine:  
 
G.  Haematemesis / Melena   
H.   Fever  
 Weight Loss:   
Loss of appetite:  
  11.  Per Abdominal Examination  
  Contour                       Skin over the abdomen   
  Abdominal movement: Respiratory:    Peristaltic:            
       Pulsatile:   
  Umbilicus     Visible mass:   
Palpation  
If Mass Present:  
  Number:   Site:    Size:   
  Shape:   Surface:   Extent:   
  Consistency:  Margins:   Tenderness:   
  Movement with respiration:   
  Plane of the swelling:   
  Free Fluid:   
Percussion  
  Liver dullness   
  Shifting dullness   
  Percussion over the mass   
Auscultation      Per-rectal examination:  
  Bowel sounds   
  Bruit          Per-vaginal examination:   
Respiratory System     Cardiovascular System  
Central Nervous System   
 
   
DIAGNOSIS:   
TREATMENT   
Procedure done:   
   
Operative findings:   
 
  HPE Report:   
 
 
 
 
 
 
 
 
 
LIST OF ABBREVIATIONS USED   
 
A/G       Albumin – Globulin ratio   
 
Ca    Carcinoma   
 
CBD     Common bile duct   
 
CT    Computed Tomography    
 
ECBD     Exploration of the CBD   
 
dL    Deciliter   
 
EU    Endoscopic Ultrasonography   
 
ERCP    Endoscopic retrograde Cholangiopancreatography   
 
IU    International Unit   
 
lab    Laboratory   
 
mg    Milligram   
 
MRCP     Magnetic resonance Cholangiopancreatography   
 
PTC     Percutaneous transhepatic cholangiography   
 
PT    Prothrombin time   
 
SD    Standard Deviation   
 
SGOT     Serum Glutamic Oxaloacetic Transaminase   
 
USG    Ultrasonography   
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1 Seetha 29 F 18116 - 1 + - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration  
2 Raja kumari 35 F 71258 + 6.1 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
3 Ranganathan 40 M 22889 + 7.4 + - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
4 Mary 42 F 17535 + 10.5 - - - - Periampullary growth whipples operation 
5 Mukayan 43 M 20256 - 1.8 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
6 Annammal 40 F 20354 + 12 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
7 Subramaniyan 42 M 27872 + 16 + + - + Periampullary growth whipples operation 
8 Marimuthu 40 M 59030 + 9 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
9 Rani 50 F 40789 - 0.9 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
10 Govindan 50 M 25944 + 21 + + - - Periampullary growth whipples operation 
11 Moorthy 52 M 22458 - 0.7 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
12 Kailasam 50 M 12741 + 15.9 + + - + Periampullary growth Triple byepass 
13 Raji 50 M 10648
0 
+ 19.2 + + - + Periampullary growth whipples operation 
14 Subramani 56 M 10408
1 
+ 20.6 + + - + Periampullary growth whipples operation 
15 Kala 50 F 33579 - 3.9 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
16 Bakthavachala
m 
55 M 35182 - 0.9 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
17 Chandrasekar 57 M 69308 + 23 + + - + Periampullary growth whipples operation 
18 Kajalaksmi 55 F 69518 - 0.8 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
19 Jyothi 50 M 79795 + 14.8 - - - - Cholelithiasis with cbd 
stricture 
open cholecystectomy with CDD 
20 Annappan 50 M 3664 + 10.6 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
21 Masthanama 50 F 15510 + 29.2 + + - + Periampullary growth whipples operation 
22 Padmavathi 57 F 20427 - 1.9 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
23 Mani 59 M 32766 - 0.8 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
24 Kuselan 52 M 27740 + 21.2 + + 
 
- + Periampullary growth whipples operation 
25 Pattabi 61 M 76152 + 17.2 - + - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
26 Sundaravalli 60 F 20270 + 19.2 - - - - Periampullary growth whipples operation 
27 maheshwari 39 F 11277
3 
+ 30.1 + + - + Mirizzi syndrome open cholecystectomy with CDD 
28 Kasi 65 M 67059 + 28.8 + + - + Periampullary growth whipples operation 
29 Subramani 62 M 74923 - 2.9 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
30 Ponnammal 63 F 34571 + 17.3 + + - - Periampullary growth Whipples operation 
31 Sulochana 60 F 35456 + 10 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
32 Raman 69 M 23283  
- 
4.9 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
33 Ayyapan 60 M 74935 + 7.9 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
34 Venkatesan 70 M 11880
7 
+ 9.6 - - - - Periampullary growth Triple byepass 
35 srinivasan 45 M 11640
0 
+ 32.0 + + - + Mirizzi syndrome open cholecystectomy with CDD 
36 Krishnan 72 M 76501 + 20.6 + + - + Periampullary growth whipples operation 
37 Govindasamy 62 M 11121
1 
- 4.9 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
38 Palani 76 M 78481 + 15.4 - - - - Periampullary growth whipples operation 
39 Chinnaiyan 57 M 10265 + 16.4 + - - - Periampullary growth whipples operation 
40 Ponni 35 F 11195 - 3.7 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
41 Varalaksmi 35 F 45984 -  3.3 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
                
42 Balu 49 M 88345 + 12.9 - - - - Cholelithiasis with cbd calculi open cholecystectomy with CDD 
43 Mariammal 37 F 11195 + 18.4 + + - + Periampullary growth whipples operation 
44 Subramani 65 M 30350 - 5.0 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
45 Lakshmi 55 F 31175 + 14.9 - - - - Periampullary growth triple byepass 
46 Parveen 41 F 38073 + 19.0 + + - - Periampullary growth whipples operation 
47 Kanniammal 45 F 35421 - 4.7 - - + - Cholelithiasis with cbd calculi Open cholecystectomy with cbd 
exploration 
48 Mariappan 48 M 75638 + 20.7 + + - + Periampullary growth whipples operation 
49 Palanivel 54 M 11269
0 
+ 13.9 - - - - Periampullary growth whipples operation 
50 Srividya 47 F 33172 + 12.6 - - - - Cholelithiasis with cbd calculi Open cholecystectomy with CDD 
 
